|
|
343 Oyster Point Blvd.
South San Francisco, CA 94080 USA
phone:650.246.6400
fax:650.246.6499
|
|
| Symbol |
DDXS |
| Exchange |
OTC Bulletin Board |
| Founded |
1997 |
| Employees |
64 |
|
|
| www.diadexus.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease |
|
| Management |
| Brian Ward, President, Chief Executive Officer; Bernard M. (Dino) Alfano, Chief Commercial Officer; David Foster, CFO; Robert L. Wolfert, Ph.D., Chief Scientific Officer; Emi Zychlinsky, Ph.D.,
Exec VP, Product Development and RA/QA & CTO |
| |
|
|
|
|
|
|
|
| Keywords |
| diagnostic, cardiovascular, IVD |
|
|
|
| Description |
|
diaDexus, Inc., is a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. |
|
| Products / Services |
diaDexus' first commercialized product is the PLAC test, an FDA-cleared blood test to assess the risk of coronary heart disease and ischemic stroke. The PLAC test provides a quantitative measurement of Lp-PLA2 (lipoprotein-associated phospholipase A2), a vascular specific inflammatory enzyme implicated in the formation of rupture-prone plaque.
|
|
| Market / Customers |
More than 60 million Americans have one or more types of cardiovascular disease, which is the leading cause of death in the United States. Half the people with CHD have normal cholesterol, indicating a clear need for additional ways to identify people at risk.
|
|
| Funding |
| diaDexus was founded in 1997 by SmithKline Beecham (now GlaxoSmithKline) and Incyte Genomics and, in April 2000, raised over $100 million in additional financing. |
|
| Status |
| In July 2010, diaDexus completed a reverse merger into VaxGen, a publicly traded company, combining diaDexus' commercial diagnostics business with VaxGen's cash resources.
diaDexus trades on the OTC Bulletin Board under the ticker symbol DDXS |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
